Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (61)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tang, D. L.
Right arrow Articles by Perera, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, D. L.
Right arrow Articles by Perera, F. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1949-1953, Copyright © 1998 by Oxford University Press

ARTICLES

Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers

DL Tang, A Rundle, D Warburton, RM Santella, WY Tsai, S Chiamprasert, YZ Hsu and FP Perera
Columbia University School of Public Health, Division of Environmental Health Sciences, New York, NY 10032, USA.

This molecular epidemiologic case-control study of lung cancer incorporated three complementary biomarkers: the glutathione S- transferase M1 (GSTM1) null genotype, a potential marker of susceptibility, and polycyclic aromatic hydrocarbon-DNA adducts (PAH- DNA) and sister chromatid exchanges (SCE), both indicators of environmentally induced genetic damage. Associations between biomarkers and lung cancer were investigated, as were possible gene-environment interactions between the GSTM1 null genotype and tobacco smoke exposure. Subjects included 136 primary non-small cell lung cancer surgical patients and 115 controls at the Columbia Presbyterian Medical Center. Questionnaire and Tumor Registry data, pre-treatment blood samples and biomarker measurements on blood were obtained. Overall, GSTM1 null genotype was significantly associated with lung cancer [odds ratio (OR) = 2.04, 95% confidence interval (CI) = 1.13-3.68]. ORs for GSTM1 and lung cancer were significant in females (2.50, 1.09-5.72) and smokers (2.25, 1.11-4.54) and not significant in males (1.4, 0.58-3.38) and non-smokers (0.88, 0.18-4.33). However, ORs for males versus females and smokers versus non-smokers did not differ significantly. The OR for GSTM1 and lung cancer in female smokers was 3.03 (1.09- 8.40), compared with 1.42 (0.53-4.06) in male smokers. In contrast to PAH-DNA adducts in leukocytes, SCE did not differ between cases and controls. Neither biomarker differed significantly between the two GSTM1 genotypes. The combined effect of elevated PAH-DNA adducts and GSTM1 genotype on case-control status (16.19, 1.2-115) appeared multiplicative. Results suggest that the effect of the GSTM1 null genotype is greatest in female smokers, which is consistent with other evidence that indicates that women are at higher risk of lung cancer than males, given equal smoking. Persons with both the GSTM1 deletion and elevated PAH-DNA adducts may represent a sensitive subpopulation with respect to carcinogens in tobacco smoke and other environmental media.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins
Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis
Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Tammemagi, M. T. Freedman, T. R. Church, M. M. Oken, W. G. Hocking, P. A. Kvale, P. Hu, T. L. Riley, L. R. Ragard, P. C. Prorok, et al.
Factors Associated with Human Small Aggressive Non Small Cell Lung Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2082 - 2089.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. D. Patel
Lung Cancer in Women
J. Clin. Oncol., May 10, 2005; 23(14): 3212 - 3218.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. D. Patel, P. B. Bach, and M. G. Kris
Lung Cancer in US Women: A Contemporary Epidemic
JAMA, April 14, 2004; 291(14): 1763 - 1768.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Ahsan and A. G. Rundle
Measures of genotype versus gene products: promise and pitfalls in cancer prevention
Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle and S. Schwartz
Issues in the Epidemiological Analysis and Interpretation of Intermediate Biomarkers
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 491 - 496.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. L. Divi, F. A. Beland, P. P. Fu, L. S. Von Tungeln, B. Schoket, J. E. Camara, M. Ghei, N. Rothman, R. Sinha, and M. C. Poirier
Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring
Carcinogenesis, December 1, 2002; 23(12): 2043 - 2049.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al.
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Whyatt, W. Jedrychowski, K. Hemminki, R. M. Santella, W.-Y. Tsai, K. Yang, and F. P. Perera
Biomarkers of Polycyclic Aromatic Hydrocarbon-DNA Damage and Cigarette Smoke Exposures in Paired Maternal and Newborn Blood Samples as a Measure of Differential Susceptibility
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 581 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. A. Mooney, F. P. Perera, A. M. Van Bennekum, W. S. Blaner, J. Karkoszka, L. Covey, Y. Hsu, T. B. Cooper, and K. Frenkel
Gender Differences in Autoantibodies to Oxidative DNA Base Damage in Cigarette Smokers
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 641 - 648.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. S. Jacobson, M. D. Begg, L. W. Wang, Q. Wang, M. Agarwal, E. Norkus, V. N. Singh, T.-L. Young, D. Yang, and R. M. Santella
Effects of a 6-Month Vitamin Intervention on DNA Damage in Heavy Smokers
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1303 - 1311.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz
Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study
J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera
The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue
Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
F. P. Perera
Molecular Epidemiology: On the Path to Prevention?
J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. B. Nia, L. M. Maas, S. G. J. Van Breda, D. M. J. Curfs, J. C. S. Kleinjans, E. F. M. Wouters, and F. J. Van Schooten
Applicability of Induced Sputum for Molecular Dosimetry of Exposure to Inhalatory Carcinogens: 32P-Postlabeling of Lipophilic DNA Adducts in Smokers and Nonsmokers
Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 367 - 372.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
M. C. Poirier, R. M. Santella, and A. Weston
Carcinogen macromolecular adducts and their measurement
Carcinogenesis, March 1, 2000; 21(3): 353 - 359.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Whyatt, F. P. Perera, W. Jedrychowski, R. M. Santella, S. Garte, and D. A. Bell
Association between Polycyclic Aromatic Hydrocarbon-DNA Adduct Levels in Maternal and Newborn White Blood Cells and Glutathione S-Transferase P1 and CYP1A1 Polymorphisms
Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 207 - 212.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch
Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism
Carcinogenesis, January 1, 2000; 21(1): 35 - 41.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. P. Bennett, M. C. R. Alavanja, B. Blomeke, K. H. Vahakangas, K. Castren, J. A. Welsh, E. D. Bowman, M. A. Khan, D. B. Flieder, and C. C. Harris
Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women
J Natl Cancer Inst, December 1, 1999; 91(23): 2009 - 2014.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Santella
Immunological Methods for Detection of Carcinogen-DNA Damage in Humans
Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 733 - 739.
[Full Text]

Home page
 JNCI J Natl Cancer InstHome page
S. S. Hecht
Tobacco Smoke Carcinogens and Lung Cancer
J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.